Inventor · disambiguated record
Jun Yuan
Also filed as: YUAN JUN
110 granted patents·21 pending applications·1,077 citations·filing 1992–2023
99Inventor score
Top patents by PatentIndex Score
131 records- 0196US6369053B12-Aminoquinolinecarboxamides: neurokinin receptor ligandsNEUROGEN CORP·Filed 2000·Granted Apr 9, 2002·46 cites·43 claims
- 0294US6559163B22,4-substituted quinoline derivativesNEUROGEN CORP·Filed 2001·Granted May 6, 2003·61 cites·31 claims
- 0393US10786576B2Fatty acids and their use in conjugation to biomoleculesNOVARTIS AG·Filed 2018·Granted Sep 29, 2020·5 cites·33 claims
- 0493US5478934ACertain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligandsFiled 1994·Granted Dec 26, 1995·40 cites·2 claims
- 0592US11466048B23′ end caps, 5′ end caps and combinations thereof for therapeutic RNANOVARTIS AG·Filed 2020·Granted Oct 11, 2022·3 cites·5 claims
- 0692US7642267B2Benzimidazole and pyridylimidazole derivativesNEUROGEN CORP·Filed 2007·Granted Jan 5, 2010·20 cites·21 claims
- 0791US6949562B2Heterocyclic compounds as ligands of the GABAA receptorPFIZER·Filed 2003·Granted Sep 27, 2005·54 cites·34 claims
- 0891US6653471B2Heterocyclic compounds as ligands of the GABAA receptorNEUROGEN CORP·Filed 2001·Granted Nov 25, 2003·54 cites·27 claims
- 0991US6175015B1Fused indolecarboxamides: dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1997·Granted Jan 16, 2001·45 cites·7 claims
- 1091US5243049ACertain pyrroloquinolinones: a new class of GABA brain receptor ligandsNEUROGEN CORP·Filed 1992·Granted Sep 7, 1993·39 cites·20 claims
- 1190US7342115B23-substituted-6-aryl pyridinesNEUROGEN CORP·Filed 2003·Granted Mar 11, 2008·35 cites·33 claims
- 1290US5594141ACertain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligandsNEUROGEN CORP·Filed 1994·Granted Jan 14, 1997·28 cites·8 claims
- 1389US6828329B2Aryl fused substituted 4-oxy-pyridinesNEUROGEN CORP·Filed 2001·Granted Dec 7, 2004·20 cites·18 claims
- 1488US10676499B23′ end caps, 5′ end caps and combinations thereof for therapeutic RNANOVARTIS AG·Filed 2015·Granted Jun 9, 2020·6 cites·2 claims
- 1588US6310212B14-substituted quinoline derivativesNEUROGEN CORP·Filed 2000·Granted Oct 30, 2001·25 cites·14 claims
- 1688US5760225ACertain pyrazole derivatives as corticotropin-releasing factor receptor CRF1 specific ligandsNEUROGEN CORP·Filed 1996·Granted Jun 2, 1998·28 cites·25 claims
- 1787US6069251ACertain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4- substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1997·Granted May 30, 2000·25 cites·9 claims
- 1887US5604235ACertain pyrroloquinolinones; a new class of gaba brain receptor ligandsNEUROGEN CORP·Filed 1993·Granted Feb 18, 1997·24 cites·7 claims
- 1985US8431593B2Heteroaryl amide derivativesHUTCHISON ALAN J·Filed 2007·Granted Apr 30, 2013·13 cites·18 claims
- 2085US6353103B1Isoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF1 specific ligandsNEUROGEN CORP·Filed 2000·Granted Mar 5, 2002·11 cites·29 claims
- 2185US5712392ACertain 4-piperidine- and piperazinoalkyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1995·Granted Jan 27, 1998·21 cites·4 claims
- 2284US9266925B2Cyclic polypeptides for the treatment of heart failureZECRI FREDERIC·Filed 2014·Granted Feb 23, 2016·8 cites·23 claims
- 2384US6469041B2Certain pyrazole derivatives as corticotropin-releasing factor CRF1 ligandsNEUROGEN CORP·Filed 2001·Granted Oct 22, 2002·13 cites·17 claims
- 2483US8338591B23-aryl-5,6-disubstituted pyridazinesYOON TAEYOUNG·Filed 2005·Granted Dec 25, 2012·14 cites·1 claims
- 2583US6515133B1Pharmaceutical compositions containing certain diarylimidazole derivativesNEUROGEN CORP·Filed 2000·Granted Feb 4, 2003·16 cites·19 claims
- 2683US6511987B1Bicyclic and tricyclic heteroaromatic compoundsNEUROGEN CORP·Filed 2000·Granted Jan 28, 2003·16 cites·59 claims
- 2783US6127399ACertain pyrazole derivatives as cortiocotropin-releasing factor receptor CRF1 specific ligandsNEUROGEN CORP·Filed 1999·Granted Oct 3, 2000·36 cites·8 claims
- 2883US5633377A4-piperidino- and piperazinomethyl-2-cyclohexyl imidazole derivatives; dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1995·Granted May 27, 1997·18 cites·4 claims
- 2982US8921307B2Synthetic linear apelin mimetics for the treatment of heart failureZECRI FRÉDÉRIC·Filed 2013·Granted Dec 30, 2014·5 cites·24 claims
- 3081US8580812B2Heteroaryl amide analogues as P2X7 antagonistsIHLE DAVID C·Filed 2008·Granted Nov 12, 2013·9 cites·26 claims
- 3181US5644057ADeazapurine derivatives; a new class of CRF1 specific ligandsNEUROGEN CORP·Filed 1995·Granted Jul 1, 1997·23 cites·28 claims
- 3280US9683019B2Cyclic polypeptides for the treatment of heart failureZECRI FREDERIC·Filed 2015·Granted Jun 20, 2017·3 cites·19 claims
- 3379US7863454B23-substituted-6-aryl pyridinesNOVARTIS INT PHARM LTD·Filed 2008·Granted Jan 4, 2011·3 cites·4 claims
- 3479US2024066132A1Novel fatty acids and their use in conjugation to biomoleculesNOVARTIS AG·Filed 2023·Application pending·0 cites
- 3578US7906528B2Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compoundsNOVARTIS INT PHARM LTD·Filed 2005·Granted Mar 15, 2011·3 cites·25 claims
- 3678US7326709B2Bicyclic and tricyclic heteroaromatic compoundsNEUROGEN CORP·Filed 2006·Granted Feb 5, 2008·2 cites·8 claims
- 3778US6358955B1Substituted imidazoles as subtype specific dopamine receptor ligands and pharmaceutical compositions containing such substituted imidazoleNEUROGEN CORP·Filed 2000·Granted Mar 19, 2002·5 cites·21 claims
- 3878US5908932ACertain pyrroloquinolinones; a new class of GABA brain receptorNEUROGEN CORP·Filed 1997·Granted Jun 1, 1999·16 cites·1 claims
- 3978US5710274AN-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1996·Granted Jan 20, 1998·38 cites·14 claims
- 4077US9340582B2Bioconjugates of synthetic apelin polypeptidesYUAN JUN·Filed 2014·Granted May 17, 2016·3 cites·12 claims
- 4177US6797824B2Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 2002·Granted Sep 28, 2004·4 cites·4 claims
- 4276US10005829B2Synthetic linear apelin mimetics for the treatment of heart failureNOVARTIS AG·Filed 2013·Granted Jun 26, 2018·3 cites·20 claims
- 4376US9908919B2Cyclic apelin derivatives for the treatment of heart failureNOVARTIS AG·Filed 2014·Granted Mar 6, 2018·3 cites·15 claims
- 4476US9683018B2Disulfide cyclic polypeptides for the treatment of heart failureZECRI FREDERIC·Filed 2014·Granted Jun 20, 2017·3 cites·21 claims
- 4576US7482350B24,5-disubstituted-2-aryl pyrimidinesNEUROGEN CORP·Filed 2005·Granted Jan 27, 2009·2 cites·37 claims
- 4675US10588980B2Fatty acids and their use in conjugation to biomoleculesNOVARTIS AG·Filed 2015·Granted Mar 17, 2020·1 cites·24 claims
- 4775US6413982B14-substituted quinoline derivativesNEUROGEN CORP·Filed 2000·Granted Jul 2, 2002·7 cites·52 claims
- 4873US6936617B2Heteroaryl substituted fused bicyclic heteroaryl compound as GABAA receptor ligandsNEUROGEN CORP·Filed 2002·Granted Aug 30, 2005·6 cites·32 claims
- 4973US6916819B2Benzimidazole and pyridylimidazole derivativesNEUROGEN CORP·Filed 2001·Granted Jul 12, 2005·5 cites·95 claims
- 5073US6548509B23-aryl substituted pyrazolo[4,3-D]pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligandsNEUROGEN CORP·Filed 2001·Granted Apr 15, 2003·5 cites·16 claims
Showing the top 50 of 131 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jun Yuan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →